StemCells, Inc. explained

StemCells, Inc.
Type:	Public
Industry:	Biotechnology
Key People:	Ian Massey (CEO) Irving L. Weissman, M.D. (Founder)
Homepage:	www.stemcellsinc.com

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.^{[1] [2]}

They are being studied in early stage trials.^{[3] [4]}

In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer.^[5]

External links

• StemCells, Inc. website

Notes and References

1. http://www.cnn.com/2012/09/07/health/spinal-cord-injuries-study/ Falco, Miriam. (Sept. 7, 2012). "A tiny step forward for spinal cord injuries."
2. http://www.globalpost.com/dispatch/news/afp/140305/science-sees-future-beyond-paralympics-0 Le Roux, Mariette. (March 5, 2014). "Science sees future beyond Paralympics."
3. http://www.clinicaltrials.gov/ct2/show/NCT02163876 http://www.clinicaltrials.gov/ct2/show/NCT02163876
4. News: StemCells Inc says spinal injury therapy shows promise. Reuters. 2015-11-18. 2015-12-23.
5. Web site: Microbot Medical Appoints Eyal Morag M.D. as Chief Medical Officer. BioSpace. en-US. 2020-03-03.